Jonathan Lim Investor

Jonathan Lim is a physician-turned-venturepreneur with a passion for pioneering transformative advancements in precision oncology and drug delivery. As Chairman and Co-Founder of Boundless Bio, Erasca, and Bonti, he has led the development and global regulatory approval of multiple therapeutic products in oncology, immunology, and drug delivery, benefiting thousands of patients worldwide. With a track record of founding and leading successful biotechnology companies, Jonathan has generated approximately $10 billion of shareholder value. His dedication to revitalizing people, planet, and perspective drives his mission-driven approach to founding, funding, and leading impactful ventures.